John B. Whelan
Chief Executive Officer at Inhalon Biopharma, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Samuel Lai | M | - |
Inhalon Biopharma, Inc.
Inhalon Biopharma, Inc. BiotechnologyHealth Technology Inhalon Biopharma, Inc. operates as a biotechnology company. It develops an inhaled immunotherapy platform for treating acute respiratory infections. The company is headquartered in Carrboro, NC. | - |
Thomas B. Ottoboni | M | 65 | 12 years | |
Richard Holoman | M | - |
DxUpClose, Inc.
DxUpClose, Inc. Miscellaneous Commercial ServicesCommercial Services DxUpClose, Inc. develops a point-of-care bacterial diagnostic antibiotic sensitivity test. The company was founded by Cyndi Nickel, James Biard and Clois Powell and is headquartered in Frisco, TX. | - |
Winnie H. Wan | M | - |
Inhalon Biopharma, Inc.
Inhalon Biopharma, Inc. BiotechnologyHealth Technology Inhalon Biopharma, Inc. operates as a biotechnology company. It develops an inhaled immunotherapy platform for treating acute respiratory infections. The company is headquartered in Carrboro, NC. | - |
Carol Nichols | F | - |
DxUpClose, Inc.
DxUpClose, Inc. Miscellaneous Commercial ServicesCommercial Services DxUpClose, Inc. develops a point-of-care bacterial diagnostic antibiotic sensitivity test. The company was founded by Cyndi Nickel, James Biard and Clois Powell and is headquartered in Frisco, TX. | - |
Jan Norton | F | - |
DxUpClose, Inc.
DxUpClose, Inc. Miscellaneous Commercial ServicesCommercial Services DxUpClose, Inc. develops a point-of-care bacterial diagnostic antibiotic sensitivity test. The company was founded by Cyndi Nickel, James Biard and Clois Powell and is headquartered in Frisco, TX. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Barry Quart | M | 67 | 11 years | |
Robert H. Rosen | M | 68 | 7 years | |
Gregory H. Turnbull | M | 85 | 26 years | |
Stephen Davis | M | 63 | 3 years | |
Jesse Hollingsworth | M | - | - | |
Michael A. Adam | M | 66 | 5 years | |
Paul Goddard | M | 74 | 12 years | |
Peter Hans Rudolf Riepenhausen | M | 87 | 18 years | |
John Barr | M | 64 | 15 years | |
Erin O’Boyle | F | - | 8 years | |
William R. Rohn | M | 80 |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | - |
Joel Schaedler | M | - | - | |
Stanford J. Stewart | M | 71 |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | 3 years |
Julian N. Stern | M | 99 | - | |
Barbara Finck | M | 77 |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | 2 years |
Michael L. Kranda | M | 69 |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | - |
Thomas A. Pitler | M | 65 | - | |
Joe K. Piper | M | - |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | 6 years |
Robert Zerbe | M | 73 | 9 years | |
Mark Gelder | M | 67 | 3 years | |
Toby Rosenblatt | M | 85 | 28 years | |
Ronald J. Prentki | M | 66 | 2 years | |
George F. Schreiner | M | 74 |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | 2 years |
Arthur Taylor | M | 67 | 3 years | |
Richard Glynne | M | - |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 31 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John B. Whelan
- Personal Network